Beyond the Glow: How Pulsed Electromagnetic Fields Actually Work

The visible plasma is the half of Tesla BioLights you can see. The pulsed electromagnetic field is the half you cannot. PEMF has been FDA-cleared for bone non-union healing since 1979 — that part is settled. What is finally being mapped is the mechanism: adenosine receptors, ion cyclotron resonance, Wnt/β-catenin pathways, calcium signaling. Here is the molecular story.

What "PEMF" actually means

Pulsed electromagnetic field therapy delivers electromagnetic energy in discrete pulses rather than a steady wave. A coil carries current; the current shifts on and off in a specific waveform; the resulting magnetic field expands and collapses; that changing field induces an electrical current in nearby conductors — which, for biology, means cells.

This is just Maxwell's equations applied to soft tissue. A changing magnetic field induces an electric field. The cells of your body contain salt solutions and ion channels — they are exquisite electrical conductors. When a PEMF passes through them, real bioelectric currents result.

The frequencies typically used in PEMF therapy are low — 1 to 100 Hz, occasionally higher harmonics. The amplitudes are low — typically 1 to 30 millitesla. These are not heat-producing fields. They do not ionize tissue. They modulate the existing bioelectric environment.

The FDA cleared this in 1979

In 1979, the FDA cleared PEMF devices for the treatment of bone non-unions — fractures that fail to heal. The story behind that clearance goes back to the 1950s and a discovery by Iwao Yasuda, a Japanese orthopedic surgeon, that bone exhibits a piezoelectric effect. Squeeze bone, and it generates a small electrical current. Bend a femur during a walking stride and the loaded side becomes negatively charged.

Yasuda's observation matters because it suggests bones use electrical signaling as part of their normal remodeling. If you can substitute the missing piezoelectric signal externally — via a pulsed magnetic field that induces the appropriate current — you should be able to restart stalled bone healing. That is exactly what the 1970s clinical trials showed, and exactly what the FDA cleared in 1979.

Forty-seven years later, PEMF is still standard of care for non-union fractures. The 2020 review in the Journal of the American Academy of Orthopaedic Surgeons^[2] walks through current clinical evidence. The 2024 review in Bioengineering^[1] goes mechanism by mechanism.

The mechanisms — finally being mapped

For decades the clinical effect was clearer than the mechanism. PEMF works; we just did not know exactly how. The last ten years of molecular biology have started to close that gap.

1. Adenosine receptor activation

PEMF appears to selectively activate adenosine A2A receptors on cell membranes^[1]. Adenosine is a critical signaling molecule for inflammation regulation, vasodilation, and tissue repair. When A2A receptors are activated, downstream effects include reduced inflammatory cytokine production and increased anti-inflammatory mediators. This is one of the cleanest molecular explanations we have for PEMF's anti-inflammatory effects.

2. Ion cyclotron resonance

This is the more exotic mechanism. Cyclotron resonance is a physics phenomenon: when a charged particle in a magnetic field is hit with a specific frequency of electromagnetic wave, it absorbs energy efficiently. The resonant frequency depends on the charge-to-mass ratio of the particle.

The Liboff hypothesis (proposed in the 1980s, still being investigated) is that biological ions like calcium, magnesium, and potassium have specific cyclotron resonance frequencies in the Earth's magnetic field, and that PEMF tuned to those frequencies can selectively modulate ion transport across cell membranes. Some PEMF devices explicitly tune to these resonance windows.

Recent work in the 2025 International Journal of Molecular Sciences^[4] revisits this mechanism with modern instruments and finds the resonance hypothesis is still consistent with observed biological effects.

3. Wnt/β-catenin and MAPK signaling

The 2024 Bioengineering review^[1] documents that PEMF activation of membrane adenosine receptors triggers intracellular cascades through Wnt/β-catenin and MAPK pathways. These are not obscure pathways. They are master regulators of cellular differentiation, bone formation, and tissue repair. The Wnt pathway in particular is a major regulator of osteoblast activity — the cells that build new bone.

This is the molecular bridge from "magnetic field" to "bone heals faster." The field activates receptors. Receptors activate signaling cascades. Cascades drive osteoblasts. Osteoblasts build bone.

4. Calcium signaling

A 2024 study^[3] demonstrated that 50 Hz magnetic fields at 1 millitesla modulate calcium homeostasis in hippocampal neurons — specifically via ryanodine receptors and SERCA pumps. The same calcium signaling cascade is implicated in PEMF-mediated healing across many tissue types. Calcium is the universal second messenger; modulating its dynamics is a high-leverage intervention.

"PEMF treatment activates adenosine A2A and A3 receptors, which in turn signal through Wnt/β-catenin and MAPK pathways to promote osteoblast differentiation and inhibit osteoclast resorption. The therapeutic effects on bone healing are no longer mysterious."
— Bioengineering review, PMC11672986, 2024

Where the Tesla coil comes in

Most clinical PEMF devices use copper coils driven by a controlled signal generator at a single low frequency. Tesla BioLights is different. The S.E.A.D. System uses a resonant high-voltage Tesla coil — the same fundamental circuit Nikola Tesla patented in 1891 — to drive the noble gas plasma tubes.

A Tesla coil is a resonant transformer. It produces extremely high voltages at radio frequencies (typically 100 kHz to several MHz for therapeutic versions). The output is not a single clean frequency — it is a complex waveform with many harmonics, packed with rapid rise-time pulses. This naturally produces a broad-spectrum PEMF as a side-effect of driving the plasma.

The biophysics implication: where a standard PEMF mat exposes tissue to one narrow band of frequencies, a Tesla coil-driven plasma device exposes tissue to a much wider spectrum simultaneously. This is closer in character to Lakhovsky's original multi-wave oscillator hypothesis from the 1920s — that broad-spectrum fields work better than single-frequency fields because cells of different sizes resonate at different frequencies.

What the field actually does in a session

During a Tesla BioLights session, the body is positioned within the resonant field of the device. The visible plasma is the part you see; the PEMF component is the part you do not. The induced currents in tissue are small — well below thresholds for any sensation other than occasional subtle warmth or tingling — but they are real, measurable, and capable of triggering the same cellular signaling cascades that the FDA-cleared bone-healing devices have been driving since 1979.

Where to read further

The full mechanism map — adenosine receptors, ion cyclotron resonance, Wnt/β-catenin, MAPK, calcium signaling, with all peer-reviewed citations — is at our science page. Tomorrow's essay: The Bioelectric Code: How Electromagnetic Fields Interface With Cellular Health — Michael Levin's work at Tufts, the transmembrane voltage premise, and how external EMF connects to gene expression.